Medical Equipment

Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01)

CPL-01, for Non-Opioid Treatment of Post-Operative Pain, Garners Publication of Clinical Data in Abdominoplasty and Presentation of Preclinical Data in Bony and Soft-Tissue ModelsSupporting Pharmacokinetics and Safety SAN DIEGO, Oct. 26, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinaft...

2022-10-27 10:07 2445

Lunit Joins World Economic Forum Global Innovators Community

* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-only group of the world's most promising start-ups and scale-ups at the forefront of technological and business model innovation * In 2020, Lunit was nominated among hundreds of candidates as one of t...

2022-10-26 21:00 3584

Meet the female scientists who develop cellular and gene therapies

SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- Inside Namtai Inno Park in Guangming District hides a low-profile biomedical development firm – Shenzhen Wingor Biotechnology Co. Upon entering the company, one may feel a different vibe – something gentle yet vibrant, maybe because it's female-domin...

2022-10-26 17:07 2957

Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK

Sweden-Gothenburg and Germany-Pforzheim, October 25, 2022 ( https://news.cision.com/mentice-ab).  GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzh...

2022-10-25 23:23 2616

MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program

MiRXES Translator Program will accelerate revenue growth of start-ups and importantly, adoption of preventive healthcare solutions globally SINGAPORE, Oct. 25, 2022 /PRNewswire/ -- MiRXES , a Singapore-headquartered biotechnology company focused on saving lives and improving...

2022-10-25 11:50 4739

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last  week "MedAlliance to be acquired by Cordis",MedAlliance is pleased to make the following announcement:  SELUTION SLR™, MedAlliance's novel sirolimus...

2022-10-25 08:00 4106

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutatio...

2022-10-24 20:14 4323

Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting

SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta is i...

2022-10-24 16:08 3694

United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT

* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...

2022-10-24 16:00 2655

United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT

* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...

2022-10-24 15:13 2877

Advanced Instruments Introduces the OsmoPRO® MAX Automated Osmometer to Maximize Clinical Lab Productivity

Our newest osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. NORWOOD, Mass., Oct. 22, 2022 /PRNewswire/ -- Recently, Advanced Instruments announce...

2022-10-22 03:01 8953

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

TAMPA, Fla., Oct. 21, 2022 /PRNewswire/ -- Concept Medical Inc.  announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA

2022-10-21 20:36 4738

EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022

Developed based on Loop-Mediated Isothermal Amplification (LAMP), the new molecular diagnostics analysis system, ClariLight CL30, gives on-the-spot results and empowers physicians for early infectious disease diagnostics because of its agility, fast and flexibility. BANGKOK, Thailand, Oct. 19, 2...

2022-10-19 19:59 3333

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST

GOTHENBURG, Sweden, Oct. 19, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presen...

2022-10-19 15:30 2181

MedAlliance to be Acquired by Cordis

GENEVA, Oct. 19, 2022 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of$35M and upfront closing payment of$200M, regulatory achievement milestones of up to $125M ...

2022-10-19 08:00 3447

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology

* Brings Eyenuk's total funding to over $43 million * Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others * Eyenuk adds three new board members * Funding affirms Eyenuk's standing as the global leader among developers of autonomous AI solutions ...

2022-10-17 19:30 2297

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

* New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials * Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve ther...

2022-10-17 13:00 3032

3M V.A.C. Therapy negative pressure wound therapy achieves key medical evidence milestone, surpassing 2,000 peer-reviewed medical journal studies published

ST. PAUL, Minn., Oct. 13, 2022 /PRNewswire/ -- 3M Health Care's Medical Solutions Division today announced its3M™ V.A.C.® Therapy negative pressure wound therapy (NPWT) has surpassed a clinical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the fir...

2022-10-13 21:10 2579

Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. HUNTINGDON VALLEY, Pa., Oct. 13...

2022-10-13 20:00 1931

Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety

* The Digital Therapeutic (DTx) was developed by DTx leader Alex Therapeutics using the proprietary "Alex DTx Platform"[1] in partnership with Vicore Pharma * In the study patients with Idiopathic Pulmonary Fibrosis (IPF) and anxiety were given the DTx * Safety, functionality, and user exper...

2022-10-13 14:39 1941
1 ... 119120121122123124125 ... 148